Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2022 Filed Oct 17, 2022 20:45 UTC |
Nguyen DiemDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-053830 · doc4.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2032-10-13 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:42 UTC |
Martell ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-053831 · doc4.xml · derivative · entry 1 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2032-10-13 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:36 UTC |
Benz Edward J. JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-053829 · doc4.xml · derivative · entry 1 Benz Edward J. JR · CIK 0001691160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2032-10-13 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:36 UTC |
Manning Paul BDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-053828 · doc4.xml · derivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2032-10-13 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:45 UTC |
Aguilar-Cordova EstuardoDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-053833 · doc4.xml · derivative · entry 1 Aguilar-Cordova Estuardo · CIK 0001873919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2032-10-13 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 16:15 UTC |
Amello JasonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 230,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001209191-22-051131 · doc4.xml · derivative · entry 1 Amello Jason · CIK 0001451805 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2032-09-21 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on September 21, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 17:05 UTC |
Nichols William GarrettChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0000899243-22-031059 · doc4.xml · derivative · entry 1 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-09-12 F1 · derivative.exercise_date: The first 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on September 12, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The remaining 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on the first anniversary of the date in which the Reporting Person converts to a full-time employee, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 12:05 UTC |
Gaeta ReneeDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,480 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000899243-22-028203 · doc4.xml · derivative · entry 1 Gaeta Renee · CIK 0001742428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,480 Underlying: Common Stock · 28,480 shares Expires 2032-08-08 F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 12:05 UTC |
PAPA JOSEPH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,480 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000899243-22-028201 · doc4.xml · derivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,480 Underlying: Common Stock · 28,480 shares Expires 2032-08-08 F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 12:05 UTC |
Nabel Gary J.Director
|
GrantStock Option (Right to Buy) · Derivative | 28,480 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000899243-22-028202 · doc4.xml · derivative · entry 1 Nabel Gary J. · CIK 0001867450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,480 Underlying: Common Stock · 28,480 shares Expires 2032-08-08 F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:07 UTC |
Aguilar Laura K.10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 76,717 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 6 Aguilar Laura K. · CIK 0001873915 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,717 shares Expires 2028-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:07 UTC |
Aguilar Laura K.10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 76,717 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 5 Aguilar Laura K. · CIK 0001873915 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,717 shares Expires 2028-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:07 UTC |
Aguilar Laura K.10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,901 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 4 Aguilar Laura K. · CIK 0001873915 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,901 shares Expires 2028-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:07 UTC |
Aguilar Laura K.10% owner
|
Tax withholdingCommon Stock | 68,534 | $3.65 | $250,149.10 |
DisclosureSEC source: 0000899243-22-017477 · doc4.xml · nonDerivative · entry 2 Aguilar Laura K. · CIK 0001873915 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,840 F2 · kind: Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share. F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:07 UTC |
Aguilar Laura K.10% owner
|
Exercise / conversionCommon Stock | 171,335 | $1.46 | $250,149.10 |
DisclosureSEC source: 0000899243-22-017477 · doc4.xml · nonDerivative · entry 1 Aguilar Laura K. · CIK 0001873915 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:04 UTC |
Aguilar-Cordova EstuardoDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 46,261 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 6 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,456 Underlying: Common Stock · 46,261 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:04 UTC |
Aguilar-Cordova EstuardoDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 76,717 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 5 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,717 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:04 UTC |
Aguilar-Cordova EstuardoDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,205 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 4 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,205 shares Expires 2028-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:04 UTC |
Aguilar-Cordova EstuardoDirector · 10% owner
|
Tax withholdingCommon Stock | 54,074 | $3.65 | $197,370.10 |
DisclosureSEC source: 0000899243-22-017474 · doc4.xml · nonDerivative · entry 2 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,032 F2 · kind: Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share. F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| May 06, 2022 Filed May 10, 2022 22:04 UTC |
Aguilar-Cordova EstuardoDirector · 10% owner
|
Exercise / conversionCommon Stock | 135,183 | $1.46 | $197,367.18 |
DisclosureSEC source: 0000899243-22-017474 · doc4.xml · nonDerivative · entry 1 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Tyagarajan SeshuSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0000899243-22-014892 · doc4.xml · derivative · entry 1 Tyagarajan Seshu · CIK 0001923794 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2032-04-14 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 14, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 17:15 UTC |
Stewart Susan B.Chief Regulatory Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0000899243-22-014591 · doc4.xml · derivative · entry 1 Stewart Susan B. · CIK 0001618249 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-04-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on May 11, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 23:34 UTC |
Barone FrancescaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-22-008370 · doc4.xml · derivative · entry 1 Barone Francesca · CIK 0001909680 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 18:40 UTC |
Canepa John JChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-22-008377 · doc4.xml · derivative · entry 1 Canepa John J · CIK 0001589238 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 23:35 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 330,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-22-008373 · doc4.xml · derivative · entry 1 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 22:40 UTC |
Barone FrancescaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0000899243-22-005079 · doc4.xml · derivative · entry 1 Barone Francesca · CIK 0001909680 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments over four years following the Grant Date, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 01:02 UTC |
Manning Paul BDirector
|
PurchaseCommon Stock | 20,000 | $7.30 | $145,944.00 |
DisclosureSEC source: 0000899243-21-030774 · doc4.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 F3 · price: The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.855 to $7.80. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:12 UTC |
Martell ChristopherDirector
|
ConversionSeries B Preferred Stock · Derivative | 696,851 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031104 · doc4.xml · derivative · entry 3 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GTAM1 2012 ADV LLC Disclosed balance after: 0 Underlying: Common Stock · 283,514 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:12 UTC |
Martell ChristopherDirector
|
PurchaseCommon Stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0000899243-21-031104 · doc4.xml · nonDerivative · entry 2 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GTAM1 2012 LLC Disclosed balance after: 125,000 F3 · ownership.nature: Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:12 UTC |
Martell ChristopherDirector
|
ConversionCommon Stock | 283,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031104 · doc4.xml · nonDerivative · entry 1 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GTAM1 2012 ADV LLC Disclosed balance after: 283,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:02 UTC |
Caffo NathanChief Business Officer
|
PurchaseCommon Stock | 6,000 | $8.00 | $48,000.00 |
DisclosureSEC source: 0000899243-21-031086 · doc4.xml · nonDerivative · entry 1 Caffo Nathan · CIK 0001816992 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:11 UTC |
Nguyen DiemDirector
|
PurchaseCommon Stock | 10,000 | $8.00 | $80,000.00 |
DisclosureSEC source: 0000899243-21-031102 · doc4.xml · nonDerivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:08 UTC |
Manning Paul BDirector
|
ConversionSeries B Preferred Stock · Derivative | 1,361,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031096 · doc4.xml · derivative · entry 5 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By BKB Growth Investments, LLC Disclosed balance after: 0 Underlying: Common Stock · 553,752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:08 UTC |
Manning Paul BDirector
|
ConversionSeries B Preferred Stock · Derivative | 1,669,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031096 · doc4.xml · derivative · entry 4 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 679,158 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:08 UTC |
Manning Paul BDirector
|
ConversionCommon Stock | 553,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031096 · doc4.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By BKB Growth Investments, LLC Disclosed balance after: 553,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:08 UTC |
Manning Paul BDirector
|
ConversionCommon Stock | 679,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031096 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 679,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:06 UTC |
Canepa John JChief Financial Officer
|
PurchaseCommon Stock | 10,125 | $8.00 | $81,000.00 |
DisclosureSEC source: 0000899243-21-031092 · doc4.xml · nonDerivative · entry 1 Canepa John J · CIK 0001589238 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,125 Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:12 UTC |
Aguilar-Cordova EstuardoDirector · Chief Scientific Officer
|
ConversionSeries B Preferred Stock · Derivative | 398,519 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031103 · doc4.xml · derivative · entry 3 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 162,137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:12 UTC |
Aguilar-Cordova EstuardoDirector · Chief Scientific Officer
|
ConversionCommon Stock | 162,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031103 · doc4.xml · nonDerivative · entry 1 Aguilar-Cordova Estuardo · CIK 0001873919 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:09 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
PurchaseCommon Stock | 25,000 | $8.00 | $200,000.00 |
DisclosureSEC source: 0000899243-21-031097 · doc4.xml · nonDerivative · entry 1 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:04 UTC |
Aguilar Laura K.Chief Medical Officer
|
ConversionSeries B Preferred Stock · Derivative | 137,881 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031088 · doc4.xml · derivative · entry 3 Aguilar Laura K. · CIK 0001873915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 00:04 UTC |
Aguilar Laura K.Chief Medical Officer
|
ConversionCommon Stock | 56,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031088 · doc4.xml · nonDerivative · entry 1 Aguilar Laura K. · CIK 0001873915 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · balance_after: Includes 32,399 shares of common stock held jointly with spouse. F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment |
Manning Paul BDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,361,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031614 · doc4a.xml · derivative · entry 5 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By BKB Growth Investments, LLC Disclosed balance after: 0 Underlying: Common Stock · 553,752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment |
Manning Paul BDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,669,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031614 · doc4a.xml · derivative · entry 4 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 679,158 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 1,625,000 | $8.00 | $13,000,000.00 |
DisclosureSEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 3 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681,000 F4 · ownership.direct: Includes shares held jointly with spouse. Read SEC document |
| July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment |
Manning Paul BDirector · 10% owner
|
ConversionCommon Stock | 553,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By BKB Growth Investments, LLC Disclosed balance after: 553,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment |
Manning Paul BDirector · 10% owner
|
ConversionCommon Stock | 679,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 679,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2021 Filed Jul 30, 2021 01:02 UTC |
Manning Paul BDirector
|
PurchaseCommon Stock | 36,000 | $7.36 | $264,834.00 |
DisclosureSEC source: 0000899243-21-030774 · doc4.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 F1 · price: The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.31 to $7.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held jointly with spouse. Read SEC document |
| July 26, 2021 Filed Feb 14, 2022 21:43 UTC |
Nguyen DiemDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,840 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006188 · doc5.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,840 Underlying: Common Stock · 28,840 shares Expires 2031-07-26 F1 · derivative.exercise_date: This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| July 26, 2021 Filed Feb 15, 2022 01:31 UTC Amendment |
Nguyen DiemDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,480 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006325 · doc5a.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,480 Underlying: Common Stock · 28,480 shares Expires 2031-07-26 F1 · derivative.exercise_date: This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.